找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

新窗
投票 SCIE期刊Therapeutic Advances in Chronic Disease 2024/2025影响因子:3.385 (THER ADV CHRONIC DIS) (2040-6223). (PHARMACOLOGY & P  ...234
Total Citations:2060; 2023 JIF:3.385; JIFRank: 118/354 ; Rank-JIF: 118; Number-of-JIF:354; 5 Year JIF:3.899; 5 Year JIF Quartile:Q2; JIF Without Self Cites:3.3; Immediacy Index:0.5; Immediacy Index-dealt:0.537; 2023 JCI:0.84; JCI Rank: 116/354 ; Total Articles:55; JCI Quartile:Q2; JCI Percentile:67.37; Eigenfactor:0.003; Normalized Eigenfactor:0.696; Article Influence Score:0.99; JIF Percentile:66.8; JIF Quartile:Q2; AIS Quartile:Q1; Citable Items:79; % of Articles in Citable items:0.6962; Cited Half-Life:3.6; Citing Half-Life:6.6; % of OA Gold:0.8987; Publisher name:ELSEVIER SCI LTD; Publisher address:125 London Wall, London, England, EC2Y 5
投票 SCIE期刊Cannabis and Cannabinoid Research 2024/2025影响因子:3.162 (CANNABIS CANNABINOID) (2578-5125). (PHARMACOLOGY & PHARMAC  ...234
Total Citations:1924; 2023 JIF:3.162; JIFRank: 126/354 ; Rank-JIF: 126; Number-of-JIF:354; 5 Year JIF:3.913; 5 Year JIF Quartile:Q2; JIF Without Self Cites:2.8; Immediacy Index:0.6; Immediacy Index-dealt:0.602; 2023 JCI:0.97; JCI Rank: 88/354 ; Total Articles:94; JCI Quartile:Q1; JCI Percentile:75.28; Eigenfactor:0.003; Normalized Eigenfactor:0.616; Article Influence Score:0.977; JIF Percentile:64.5; JIF Quartile:Q2; AIS Quartile:Q1; Citable Items:106; % of Articles in Citable items:0.8868; Cited Half-Life:3.6; Citing Half-Life:7.1; % of OA Gold:0.1232; Publisher name:MARY ANN LIEBERT, INC; Publisher address:140 HUGUENOT STREET, 3RD FL, NEW R
投票 SCIE期刊JOURNAL OF ASIAN NATURAL PRODUCTS RESEARCH 2024/2025影响因子:1.362 (J ASIAN NAT PROD RES) (1028-6020). (PHARMACOLOGY  ...234
Total Citations:3184; 2023 JIF:1.362; JIFRank: 283/354 ; Rank-JIF: 283; Number-of-JIF:354; 5 Year JIF:1.581; 5 Year JIF Quartile:Q4; JIF Without Self Cites:1.3; Immediacy Index:0.4; Immediacy Index-dealt:0.456; 2023 JCI:0.36; JCI Rank: 278/354 ; Total Articles:77; JCI Quartile:Q3; JCI Percentile:15.97; Eigenfactor:0.002; Normalized Eigenfactor:0.338; Article Influence Score:0.248; JIF Percentile:11.8; JIF Quartile:Q4; AIS Quartile:Q4; Citable Items:81; % of Articles in Citable items:0.9506; Cited Half-Life:8.6; Citing Half-Life:8.7; % of OA Gold:0.003; Publisher name:GETTY RESEARCH INST; Publisher address:1200 Getty Center Dr, Ste 1100, Los A
投票 SCIE期刊BIOMEDICINE & PHARMACOTHERAPY 2024/2025影响因子:6.943 (BIOMED PHARMACOTHER) (0753-3322). (PHARMACOLOGY & PHARMACY)(药理  ...234
Total Citations:66180; 2023 JIF:6.943; JIFRank: 15/354 ; Rank-JIF: 15; Number-of-JIF:354; 5 Year JIF:6.827; 5 Year JIF Quartile:Q1; JIF Without Self Cites:6.6; Immediacy Index:1.3; Immediacy Index-dealt:1.356; 2023 JCI:1.57; JCI Rank: 25/354 ; Total Articles:1178; JCI Quartile:Q1; JCI Percentile:93.08; Eigenfactor:0.072; Normalized Eigenfactor:15.621; Article Influence Score:1.139; JIF Percentile:95.9; JIF Quartile:Q1; AIS Quartile:Q1; Citable Items:1743; % of Articles in Citable items:0.6758; Cited Half-Life:4; Citing Half-Life:5.8; % of OA Gold:0.9676; Publisher name:WILEY; Publisher address:111 RIVER ST, HOBOKEN, USA, NJ, 07030;
投票 SCIE期刊INTERNATIONAL JOURNAL OF TOXICOLOGY 2024/2025影响因子:1.249 (INT J TOXICOL) (1091-5818). (PHARMACOLOGY & PHARMACY)(药理  ...234
Total Citations:2274; 2023 JIF:1.249; JIFRank: 290/354 ; Rank-JIF: 290; Number-of-JIF:354; 5 Year JIF:2.263; 5 Year JIF Quartile:Q3; JIF Without Self Cites:1.1; Immediacy Index:0.1; Immediacy Index-dealt:0.139; 2023 JCI:0.44; JCI Rank: 257/354 ; Total Articles:81; JCI Quartile:Q4; JCI Percentile:11.79; Eigenfactor:0.001; Normalized Eigenfactor:0.208; Article Influence Score:0.457; JIF Percentile:8; JIF Quartile:Q4; AIS Quartile:Q4; Citable Items:87; % of Articles in Citable items:0.931; Cited Half-Life:11.3; Citing Half-Life:12.3; % of OA Gold:0.0833; Publisher name:JAPANESE SOC FOOD SCI & TECHNOLOGY; Publisher address:c/o National Food Resea
投票 SCIE期刊VASCULAR PHARMACOLOGY 2024/2025影响因子:3.532 (VASC PHARMACOL) (1537-1891). (PHARMACOLOGY & PHARMACY)(药理学与药学)Science  ...234
Total Citations:3382; 2023 JIF:3.532; JIFRank: 100/354 ; Rank-JIF: 100; Number-of-JIF:354; 5 Year JIF:4.159; 5 Year JIF Quartile:Q2; JIF Without Self Cites:3.4; Immediacy Index:0.5; Immediacy Index-dealt:0.558; 2023 JCI:1.24; JCI Rank: 52/354 ; Total Articles:65; JCI Quartile:Q1; JCI Percentile:85.45; Eigenfactor:0.003; Normalized Eigenfactor:0.556; Article Influence Score:0.919; JIF Percentile:71.9; JIF Quartile:Q2; AIS Quartile:Q2; Citable Items:68; % of Articles in Citable items:0.9559; Cited Half-Life:7.4; Citing Half-Life:7.4; % of OA Gold:0.2745; Publisher name:SAGE PUBLICATIONS LTD; Publisher address:1 OLIVERS YARD, 55 CITY ROAD, LONDO
投票 SCIE期刊AMERICAN JOURNAL OF THERAPEUTICS 2024/2025影响因子:2.904 (AM J THER) (1075-2765). (PHARMACOLOGY & PHARMACY)(药理学与药学)Sc  ...234
Total Citations:2002; 2023 JIF:2.904; JIFRank: 147/354 ; Rank-JIF: 147; Number-of-JIF:354; 5 Year JIF:2.592; 5 Year JIF Quartile:Q3; JIF Without Self Cites:2.7; Immediacy Index:1.4; Immediacy Index-dealt:1.451; 2023 JCI:0.73; JCI Rank: 154/354 ; Total Articles:32; JCI Quartile:Q2; JCI Percentile:56.64; Eigenfactor:0.001; Normalized Eigenfactor:0.299; Article Influence Score:0.586; JIF Percentile:58.6; JIF Quartile:Q2; AIS Quartile:Q3; Citable Items:37; % of Articles in Citable items:0.8649; Cited Half-Life:7.5; Citing Half-Life:7.2; % of OA Gold:0.0294; Publisher name:UNIV AGRONOMIC SCIENCES & VETERINARY MEDICINE BUCHAREST - USAMV; Publisher
投票 SCIE期刊Recent Patents on Anti-Cancer Drug Discovery 2024/2025影响因子:2.558 (RECENT PAT ANTI-CANC) (1574-8928). (PHARMACOLOG  ...234
Total Citations:999; 2023 JIF:2.558; JIFRank: 180/354 ; Rank-JIF: 180; Number-of-JIF:354; 5 Year JIF:2.619; 5 Year JIF Quartile:Q3; JIF Without Self Cites:2.4; Immediacy Index:2.1; Immediacy Index-dealt:2.171; 2023 JCI:0.5; JCI Rank: 236/354 ; Total Articles:16; JCI Quartile:Q3; JCI Percentile:33.47; Eigenfactor:0.001; Normalized Eigenfactor:0.125; Article Influence Score:0.436; JIF Percentile:49.3; JIF Quartile:Q3; AIS Quartile:Q3; Citable Items:38; % of Articles in Citable items:0.4211; Cited Half-Life:6; Citing Half-Life:6; % of OA Gold:0; Publisher name:SAGE PUBLICATIONS LTD; Publisher address:1 OLIVERS YARD, 55 CITY ROAD, LONDON, ENGLAND
投票 SCIE期刊Expert Opinion on Drug Metabolism & Toxicology 2024/2025影响因子:3.996 (EXPERT OPIN DRUG MET) (1742-5255). (PHARMACOL  ...234
Total Citations:4847; 2023 JIF:3.996; JIFRank: 85/354 ; Rank-JIF: 85; Number-of-JIF:354; 5 Year JIF:4.316; 5 Year JIF Quartile:Q1; JIF Without Self Cites:3.8; Immediacy Index:0.5; Immediacy Index-dealt:0.522; 2023 JCI:0.55; JCI Rank: 218/354 ; Total Articles:22; JCI Quartile:Q3; JCI Percentile:38.56; Eigenfactor:0.003; Normalized Eigenfactor:0.738; Article Influence Score:1.026; JIF Percentile:76.1; JIF Quartile:Q1; AIS Quartile:Q1; Citable Items:78; % of Articles in Citable items:0.2821; Cited Half-Life:7.8; Citing Half-Life:7; % of OA Gold:0.1628; Publisher name:ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD; Publisher address:2-4 PARK SQUARE, MI
投票 SCIE期刊DARU-Journal of Pharmaceutical Sciences 2024/2025影响因子:2.544 (DARU) (NULL). (PHARMACOLOGY & PHARMACY)(药理学与药学)Scien  ...234
Total Citations:2211; 2023 JIF:2.544; JIFRank: 180/354 ; Rank-JIF: 180; Number-of-JIF:354; 5 Year JIF:4.209; 5 Year JIF Quartile:Q1; JIF Without Self Cites:2.5; Immediacy Index:0.4; Immediacy Index-dealt:0.444; 2023 JCI:0.85; JCI Rank: 112/354 ; Total Articles:35; JCI Quartile:Q2; JCI Percentile:68.5; Eigenfactor:0.001; Normalized Eigenfactor:0.288; Article Influence Score:0.689; JIF Percentile:49.3; JIF Quartile:Q3; AIS Quartile:Q2; Citable Items:42; % of Articles in Citable items:0.8333; Cited Half-Life:7.5; Citing Half-Life:6.5; % of OA Gold:0.0667; Publisher name:WILEY-V C H VERLAG GMBH; Publisher address:POSTFACH 101161, WEINHEIM, GERMAN
投票 SCIE期刊Journal of Pharmaceutical and Biomedical Analysis 2024/2025影响因子:3.116 (J PHARMACEUT BIOMED) (0731-7085). (PHARMAC  ...234
Total Citations:24171; 2023 JIF:3.116; JIFRank: 126/354 ; Rank-JIF: 126; Number-of-JIF:354; 5 Year JIF:3.182; 5 Year JIF Quartile:Q2; JIF Without Self Cites:2.9; Immediacy Index:0.6; Immediacy Index-dealt:0.606; 2023 JCI:0.88; JCI Rank: 105/354 ; Total Articles:582; JCI Quartile:Q2; JCI Percentile:70.48; Eigenfactor:0.014; Normalized Eigenfactor:2.993; Article Influence Score:0.499; JIF Percentile:64.5; JIF Quartile:Q2; AIS Quartile:Q3; Citable Items:589; % of Articles in Citable items:0.9881; Cited Half-Life:7; Citing Half-Life:6.3; % of OA Gold:0.1262; Publisher name:SPRINGER; Publisher address:ONE NEW YORK PLAZA, SUITE 4600 , NEW YORK, Uni
投票 SCIE期刊EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY 2024/2025影响因子:2.481 (EUR J CLIN PHARMACOL) (0031-6970). (PHARMACOLOGY &  ...234
Total Citations:7968; 2023 JIF:2.481; JIFRank: 188/354 ; Rank-JIF: 188; Number-of-JIF:354; 5 Year JIF:2.567; 5 Year JIF Quartile:Q3; JIF Without Self Cites:2.3; Immediacy Index:0.4; Immediacy Index-dealt:0.481; 2023 JCI:0.62; JCI Rank: 192/354 ; Total Articles:108; JCI Quartile:Q3; JCI Percentile:45.9; Eigenfactor:0.005; Normalized Eigenfactor:1.142; Article Influence Score:0.702; JIF Percentile:47; JIF Quartile:Q3; AIS Quartile:Q2; Citable Items:153; % of Articles in Citable items:0.7059; Cited Half-Life:10.2; Citing Half-Life:6.9; % of OA Gold:0.3262; Publisher name:PERGAMON-ELSEVIER SCIENCE LTD; Publisher address:THE BOULEVARD, LANGFORD LA
投票 SCIE期刊Journal of Pharmaceutical Innovation 2024/2025影响因子:2.775 (J PHARM INNOV) (1872-5120). (PHARMACOLOGY & PHARMACY)(药  ...234
Total Citations:1556; 2023 JIF:2.775; JIFRank: 167/354 ; Rank-JIF: 167; Number-of-JIF:354; 5 Year JIF:2.825; 5 Year JIF Quartile:Q2; JIF Without Self Cites:2.7; Immediacy Index:0.5; Immediacy Index-dealt:0.552; 2023 JCI:0.64; JCI Rank: 183/354 ; Total Articles:104; JCI Quartile:Q3; JCI Percentile:48.45; Eigenfactor:0.001; Normalized Eigenfactor:0.283; Article Influence Score:0.419; JIF Percentile:53; JIF Quartile:Q2; AIS Quartile:Q3; Citable Items:104; % of Articles in Citable items:1; Cited Half-Life:3.7; Citing Half-Life:7.8; % of OA Gold:0.1066; Publisher name:ELSEVIER; Publisher address:RADARWEG 29, AMSTERDAM, Netherlands, 1043 NX;
投票 SCIE期刊ANTIVIRAL THERAPY 2024/2025影响因子:1.335 (ANTIVIR THER) (1359-6535). (PHARMACOLOGY & PHARMACY)(药理学与药学)Science Citati  ...234
Total Citations:1736; 2023 JIF:1.335; JIFRank: 283/354 ; Rank-JIF: 283; Number-of-JIF:354; 5 Year JIF:1.548; 5 Year JIF Quartile:Q4; JIF Without Self Cites:1.3; Immediacy Index:0.6; Immediacy Index-dealt:0.652; 2023 JCI:0.22; JCI Rank: 309/354 ; Total Articles:17; JCI Quartile:Q4; JCI Percentile:12.85; Eigenfactor:0.001; Normalized Eigenfactor:0.204; Article Influence Score:0.445; JIF Percentile:20.2; JIF Quartile:Q4; AIS Quartile:Q3; Citable Items:23; % of Articles in Citable items:0.7391; Cited Half-Life:11.1; Citing Half-Life:6.6; % of OA Gold:0.6184; Publisher name:SPRINGER; Publisher address:ONE NEW YORK PLAZA, SUITE 4600 , NEW YORK, Uni
投票 SCIE期刊Iranian Journal of Pharmaceutical Research 2024/2025影响因子:1.873 (IRAN J PHARM RES) (1735-0328). (PHARMACOLOGY & PH  ...234
Total Citations:3911; 2023 JIF:1.873; JIFRank: 240/354 ; Rank-JIF: 240; Number-of-JIF:354; 5 Year JIF:2.189; 5 Year JIF Quartile:Q3; JIF Without Self Cites:1.8; Immediacy Index:0.1; Immediacy Index-dealt:0.165; 2023 JCI:0.43; JCI Rank: 262/354 ; Total Articles:42; JCI Quartile:Q3; JCI Percentile:26.13; Eigenfactor:0.002; Normalized Eigenfactor:0.461; Article Influence Score:0.31; JIF Percentile:32.3; JIF Quartile:Q3; AIS Quartile:Q4; Citable Items:43; % of Articles in Citable items:0.9767; Cited Half-Life:7; Citing Half-Life:7.3; % of OA Gold:0.4598; Publisher name:TAYLOR & FRANCIS INC; Publisher address:530 WALNUT STREET, STE 850, PHILADELPH
投票 SCIE期刊EXPERT OPINION ON THERAPEUTIC PATENTS 2024/2025影响因子:5.474 (EXPERT OPIN THER PAT) (1354-3776). (PHARMACOLOGY & PHA  ...234
Total Citations:4249; 2023 JIF:5.474; JIFRank: 32/354 ; Rank-JIF: 32; Number-of-JIF:354; 5 Year JIF:6.459; 5 Year JIF Quartile:Q1; JIF Without Self Cites:5.3; Immediacy Index:1.5; Immediacy Index-dealt:1.582; 2023 JCI:0.85; JCI Rank: 112/354 ; Total Articles:6; JCI Quartile:Q2; JCI Percentile:68.5; Eigenfactor:0.003; Normalized Eigenfactor:0.685; Article Influence Score:1.253; JIF Percentile:91.1; JIF Quartile:Q1; AIS Quartile:Q1; Citable Items:54; % of Articles in Citable items:0.1111; Cited Half-Life:6.3; Citing Half-Life:5.3; % of OA Gold:0.0414; Publisher name:SAGE PUBLICATIONS LTD; Publisher address:1 OLIVERS YARD, 55 CITY ROAD, LONDON,
投票 SCIE期刊ANTIVIRAL RESEARCH 2024/2025影响因子:4.589 (ANTIVIR RES) (0166-3542). (PHARMACOLOGY & PHARMACY)(药理学与药学)Science Citati  ...234
Total Citations:11997; 2023 JIF:4.589; JIFRank: 60/354 ; Rank-JIF: 60; Number-of-JIF:354; 5 Year JIF:5.131; 5 Year JIF Quartile:Q1; JIF Without Self Cites:4.3; Immediacy Index:1.1; Immediacy Index-dealt:1.107; 2023 JCI:1.76; JCI Rank: 17/354 ; Total Articles:184; JCI Quartile:Q1; JCI Percentile:93.9; Eigenfactor:0.01; Normalized Eigenfactor:2.183; Article Influence Score:1.271; JIF Percentile:79.3; JIF Quartile:Q1; AIS Quartile:Q1; Citable Items:185; % of Articles in Citable items:0.9946; Cited Half-Life:7.3; Citing Half-Life:5.9; % of OA Gold:0.4499; Publisher name:SAGE PUBLICATIONS INC; Publisher address:2455 TELLER RD, THOUSAND OAKS, USA,
投票 SCIE期刊KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY 2024/2025影响因子:1.665 (KOREAN J PHYSIOL PHA) (1226-4512). (PHARMACOLOGY  ...234
Total Citations:1431; 2023 JIF:1.665; JIFRank: 259/354 ; Rank-JIF: 259; Number-of-JIF:354; 5 Year JIF:1.988; 5 Year JIF Quartile:Q3; JIF Without Self Cites:1.5; Immediacy Index:0.3; Immediacy Index-dealt:0.386; 2023 JCI:0.55; JCI Rank: 218/354 ; Total Articles:48; JCI Quartile:Q4; JCI Percentile:22.94; Eigenfactor:0.001; Normalized Eigenfactor:0.167; Article Influence Score:0.316; JIF Percentile:20.6; JIF Quartile:Q4; AIS Quartile:Q4; Citable Items:51; % of Articles in Citable items:0.9412; Cited Half-Life:7.3; Citing Half-Life:6.3; % of OA Gold:1; Publisher name:TAYLOR & FRANCIS LTD; Publisher address:2-4 PARK SQUARE, MILTON PARK, ABINGDON,
投票 SCIE期刊Expert Opinion on Drug Discovery 2024/2025影响因子:6.154 (EXPERT OPIN DRUG DIS) (1746-0441). (PHARMACOLOGY & PHARMACY  ...234
Total Citations:5937; 2023 JIF:6.154; JIFRank: 29/354 ; Rank-JIF: 29; Number-of-JIF:354; 5 Year JIF:6.616; 5 Year JIF Quartile:Q1; JIF Without Self Cites:5.9; Immediacy Index:1; Immediacy Index-dealt:1.196; 2023 JCI:0.7; JCI Rank: 163/354 ; Total Articles:22; JCI Quartile:Q2; JCI Percentile:54.1; Eigenfactor:0.005; Normalized Eigenfactor:1.042; Article Influence Score:1.353; JIF Percentile:91.9; JIF Quartile:Q1; AIS Quartile:Q1; Citable Items:103; % of Articles in Citable items:0.2136; Cited Half-Life:6.2; Citing Half-Life:5.8; % of OA Gold:0.1386; Publisher name:ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD; Publisher address:2-4 PARK SQUARE, MIL
投票 SCIE期刊PULMONARY PHARMACOLOGY & THERAPEUTICS 2024/2025影响因子:3.384 (PULM PHARMACOL THER) (1094-5539). (PHARMACOLOGY & PHAR  ...234
Total Citations:2818; 2023 JIF:3.384; JIFRank: 118/354 ; Rank-JIF: 118; Number-of-JIF:354; 5 Year JIF:2.826; 5 Year JIF Quartile:Q2; JIF Without Self Cites:3.3; Immediacy Index:0.5; Immediacy Index-dealt:0.592; 2023 JCI:0.84; JCI Rank: 116/354 ; Total Articles:46; JCI Quartile:Q2; JCI Percentile:66.83; Eigenfactor:0.002; Normalized Eigenfactor:0.402; Article Influence Score:0.642; JIF Percentile:68.5; JIF Quartile:Q2; AIS Quartile:Q3; Citable Items:49; % of Articles in Citable items:0.9388; Cited Half-Life:8.5; Citing Half-Life:5.7; % of OA Gold:0.2013; Publisher name:ELSEVIER SCIENCE SA; Publisher address:PO BOX 564, LAUSANNE, SWITZERLAND, 1
下一页 »
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-5-1 13:46
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
返回顶部 返回版块